Reverse Rett is a patient advocacy and research organisation working to deliver treatments and a cure for Rett Syndrome to everyone affected. In 2007, with the successful reversal of Rett Syndrome in the lab, we entered a new era for research in which we knew a cure was possible. Over the last decade, we’ve invested in high quality research projects such as the RSRT gene therapy, and Mecp2 Consortia, which have delivered viable potential treatments to industry partners, for development into human clinical trials. In 2022, these trials are firmly on the horizon and at Reverse Rett, we’re focused on doing what we need to do to build UK medical capacity to deliver complex emerging treatments for Rett Syndrome as soon as humanly possible.

CAUSE DONORS

Still no donations